Joseph J Sacco

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Squamous Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

Nature reviews. Clinical oncology

Molecular cancer research : MCR

Nature medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Joseph J Sacco, Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason John Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Chris Holland, Takami Sato
Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma. Journal for immunotherapy of cancer 12 (6) (2024)
Richard D Carvajal, Joseph J Sacco, Martine J Jager, David J Eschelman, Roger Olofsson Bagge, J William Harbour, Nicholas D Chieng, Sapna P Patel, Anthony M Joshua, Sophie Piperno-Neumann
Advances in the clinical management of uveal melanoma. Nature reviews. Clinical oncology 20 (2) (2023)
Richard D Carvajal, Joseph J Sacco, Martine J Jager, David J Eschelman, Roger Olofsson Bagge, J William Harbour, Nicholas D Chieng, Sapna P Patel, Anthony M Joshua, Sophie Piperno-Neumann
Advances in the clinical management of uveal melanoma. Nature reviews. Clinical oncology (2023)
Richard D Carvajal, Joseph J Sacco, Martine J Jager, David J Eschelman, Roger Olofsson Bagge, J William Harbour, Nicholas D Chieng, Sapna P Patel, Anthony M Joshua, Sophie Piperno-Neumann
Advances in the clinical management of uveal melanoma. Nature reviews. Clinical oncology 20 (2) (2023)
Sarah E Barnett, Jenna Kenyani, Martina Tripari, Zohra Butt, Rudi Grosman, Francesca Querques, Liam Shaw, Luisa C Silva, Zoe Goate, Stefan John Marciniak, Doris M Rassl, Richard J Jackson, Lu-Yun Lian, Peter W Szlosarek, Joseph J Sacco, Judy M Coulson
BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification. Molecular cancer research : MCR (2023)
Richard D Carvajal, Joseph J Sacco, Martine J Jager, David J Eschelman, Roger Olofsson Bagge, J William Harbour, Nicholas D Chieng, Sapna P Patel, Anthony M Joshua, Sophie Piperno-Neumann
Advances in the clinical management of uveal melanoma. Nature reviews. Clinical oncology 20 (2) (2023)
Sarah E Barnett, Jenna Kenyani, Martina Tripari, Zohra Butt, Rudi Grosman, Francesca Querques, Liam Shaw, Luisa C Silva, Zoe Goate, Stefan John Marciniak, Doris M Rassl, Richard J Jackson, Lu-Yun Lian, Peter W Szlosarek, Joseph J Sacco, Judy M Coulson
BAP1 loss is associated with higher ASS1 expression in epithelioid mesothelioma: implications for therapeutic stratification. Molecular cancer research : MCR (2023)
Richard D Carvajal, Paul D Nathan, Joseph J Sacco, Marlana Orloff, Leonel F Hernandez-Aya, Jessica Yang, Jason John Luke, Marcus O Butler, Sarah Stanhope, Laura Collins, Cheryl McAlpine, Chris Holland, Shaad E Abdullah, Takami Sato
Phase I Study of Safety, Tolerability, and Efficacy of Tebentafusp Using a Step-Up Dosing Regimen and Expansion in Patients With Metastatic Uveal Melanoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (17) (2022)
Richard D Carvajal, Marcus O Butler, Alexander N Shoushtari, Jessica C Hassel, Alexandra P Ikeguchi, Leonel Hernandez-Aya, Paul Nathan, Omid Hamid, Josep M Piulats, Matthew Rioth, Douglas B Johnson, Jason J Luke, Enrique Espinosa, Serge Leyvraz, Laura Collins, Howard M Goodall, Koustubh Ranade, Chris Holland, Shaad E Abdullah, Joseph J Sacco, Takami Sato
Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial. Nature medicine 28 (11) (2022)
Weiyu Ye, Anna Olsson-Brown, Robert A Watson, Vincent T F Cheung, Robert D Morgan, Isar Nassiri, Rosalin Cooper, Chelsea A Taylor, Umair Akbani, Oliver Brain, Rubeta N Matin, Nicholas Coupe, Mark Ross Middleton, Mark Coles, Joseph J Sacco, Miranda J Payne, Benjamin P Fairfax
Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. British journal of cancer 124 (10) (2021)